China has made remarkable progress in controlling chronic hepatitis B virus (HBV) infection over the past three decades. The prevalence of hepatitis B surface antigen has declined from 9.72% in 1992 to 5.86% in 2020, with a striking reduction from 9.67% to 0.30% among children under five. Universal hepatitis B vaccination has been pivotal, preventing more than 40 million infections and seven million HBV-related deaths since 1992. Nevertheless, an estimated 75 million individuals are currently living with chronic HBV infection in China. Among them, only 59.78% are aware of their infection status, and about 30 million remain undiagnosed. Of those diagnosed, 38.25% (approximately 17 million) meet the criteria for antiviral treatment, yet only 17.33% (about three million) are receiving treatment. To accelerate progress toward the World Health Organization’s elimination targets, China has updated its clinical guidelines to expand treatment eligibility and improve diagnosis and treatment coverage. Moreover, Chinese pharmaceutical companies and academic institutions are actively engaged in developing novel therapies with promising efficacy, aiming to achieve a functional cure. China’s holistic approach, combining evidence-based public health interventions with active clinical management and innovative pharmaceutical development, provides valuable experience for global HBV elimination initiatives. This review aimed to summarize China's progress in HBV control, identify remaining gaps in diagnosis and treatment, and highlight strategic approaches, including public health interventions, clinical policy updates, and pharmaceutical innovation, toward achieving HBV elimination.

A team of researchers from Universidad Carlos III de Madrid (UC3M), the Massachusetts Institute of Technology (MIT) and Adobe Research have presented Imprinto, a system for embedding invisible digital information in printed documents using infrared ink and a special camera. This technology introduces a new generation of hybrid interfaces between paper and augmented reality.

New research identifies the key causes of changes affecting river deltas around the world and warns of an urgent need to tackle them through climate adaptation and policy.

Deltas are low-lying areas that form as rivers and empty their water and sediment into another body of water, such as an ocean, lake, or another river.

Some of the largest in the world, such as the Rhine, Mekong, Ganges-Brahmaputra-Meghna, and Nile, are threatened by climate change, facing rising sea levels and increasing frequency of extreme events.

With approximately 500 million people today living within or adjacent to delta systems, this is a major issue.​

Australian scientists have successfully developed a research system that uses ‘biological artificial intelligence’ to design and evolve molecules with new or improved functions directly in mammal cells. The researchers said this system provides a powerful new tool that will help scientists develop more specific and effective research tools or gene therapies.

A new study by the Konrad Adenauer Program for Jewish-Arab Cooperation at TAU's Moshe Dayan Center finds that a large majority (73.2%) of Israel's Arab citizens support the inclusion of an Arab party in the government that will be formed after the next elections. In addition, the turnout of Arab voters is expected to increase.